Relics associated with Jesus

GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe

Retrieved on: 
Friday, April 10, 2020
Oncology, Health, Genetics, Clinical trials, Research, Science, Pharmaceutical, Harpal, Relics associated with Jesus, Grails, Holy Grail, Cancer, Christianity, Literature, Legends

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the appointment of Sir Harpal Kumar as President of GRAIL Europe.

Key Points: 
  • GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the appointment of Sir Harpal Kumar as President of GRAIL Europe.
  • In this new role, Sir Harpal will be responsible for leading GRAILs entry and growth in Europe.
  • I'm thrilled to be joining GRAIL and to have the opportunity to transform cancer care through early detection, said Sir Harpal.
  • Sir Harpal joins GRAIL from Johnson & Johnson where he most recently served as Senior Vice President and Head of Innovation EMEA.

GRAIL Appoints Matthew Young as Chief Operating Officer and Chief Financial Officer

Retrieved on: 
Tuesday, October 8, 2019
Biotechnology, Health, Pharmaceutical, Oncology, Holy Grail, Christian mythology, Relics associated with Jesus, Christianity, Grail, Mythology, Legends

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced that Matthew P. Young has been appointed Chief Operating Officer and Chief Financial Officer effective October 28, 2019.

Key Points: 
  • GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced that Matthew P. Young has been appointed Chief Operating Officer and Chief Financial Officer effective October 28, 2019.
  • GRAIL will be well served by Matts significant industry experience in finance and operations, and we are excited to welcome him to GRAIL.
  • I look forward to joining the GRAIL team and working together to make a transformational impact on the future of cancer care.
  • Mr. Young joins GRAIL from Jazz Pharmaceuticals, a biopharmaceutical company, where he most recently served as the companys Executive Vice President and Chief Financial Officer.